137 related articles for article (PubMed ID: 25709332)
1. Prediction of anticancer property of bowsellic acid derivatives by quantitative structure activity relationship analysis and molecular docking study.
Satpathy R; Guru RK; Behera R; Nayak B
J Pharm Bioallied Sci; 2015; 7(1):21-5. PubMed ID: 25709332
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
Yadav D; Nath Mishra B; Khan F
J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
[TBL] [Abstract][Full Text] [Related]
3. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
4. In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking.
Wang JL; Li L; Hu MB; Wu B; Fan WX; Peng W; Wei DN; Wu CJ
Comput Biol Chem; 2019 Feb; 78():297-305. PubMed ID: 30605855
[TBL] [Abstract][Full Text] [Related]
5. QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity.
Alam S; Khan F
J Biomol Struct Dyn; 2018 Jul; 36(9):2373-2390. PubMed ID: 28705120
[TBL] [Abstract][Full Text] [Related]
6. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
[TBL] [Abstract][Full Text] [Related]
7. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
8. Quinazoline analogues as cytotoxic agents; QSAR, docking, and
Emami L; Sabet R; Khabnadideh S; Faghih Z; Thayori P
Res Pharm Sci; 2021 Oct; 16(5):528-546. PubMed ID: 34522200
[TBL] [Abstract][Full Text] [Related]
9. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
[TBL] [Abstract][Full Text] [Related]
10. SAR, QSAR and docking of anticancer flavonoids and variants: a review.
Scotti L; Bezerra Mendonça Junior FJ; Magalhaes Moreira DR; da Silva MS; Pitta IR; Scotti MT
Curr Top Med Chem; 2012; 12(24):2785-809. PubMed ID: 23368103
[TBL] [Abstract][Full Text] [Related]
11. Multi-target QSAR and docking study of steroids binding to corticosteroid-binding globulin and sex hormone-binding globulin.
Nikolic K; Filipic S; Agbaba D
Curr Comput Aided Drug Des; 2012 Dec; 8(4):296-308. PubMed ID: 22242800
[TBL] [Abstract][Full Text] [Related]
12. Dataset on the DFT-QSAR, and docking approaches for anticancer activities of 1, 2, 3-triazole-pyrimidine derivatives against human esophageal carcinoma (EC-109).
Adegoke RO; Oyebamiji AK; Semire B
Data Brief; 2020 Aug; 31():105963. PubMed ID: 32695851
[TBL] [Abstract][Full Text] [Related]
13. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
14. Results of molecular docking as descriptors to predict human serum albumin binding affinity.
Chen L; Chen X
J Mol Graph Model; 2012 Mar; 33():35-43. PubMed ID: 22153983
[TBL] [Abstract][Full Text] [Related]
15. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
Abbasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
[TBL] [Abstract][Full Text] [Related]
16. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
17. Classical QSAR and Docking Simulation of 4-Pyridone Derivatives for Their Antimalarial Activity.
Flores-Sumoza M; Alcázar JJ; Márquez E; Mora JR; Lezama J; Puello E
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513742
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
19. A quantitative structure-activity relationship (QSAR) study of some diaryl urea derivatives of B-RAF inhibitors.
Sadeghian-Rizi S; Sakhteman A; Hassanzadeh F
Res Pharm Sci; 2016 Dec; 11(6):445-453. PubMed ID: 28003837
[TBL] [Abstract][Full Text] [Related]
20. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
Yadav DK; Kalani K; Khan F; Srivastava SK
Med Chem; 2013 Dec; 9(8):1073-84. PubMed ID: 23675978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]